Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lurasidone in patients with schizophrenia

Next Previous
Search
Trial Profile

Lurasidone in patients with schizophrenia

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lurasidone (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Sumitomo Pharmaceuticals

    • Most Recent Events

    • 20 Sep 2016 Results of pooled, post hoc analysis of this and other four trials presented at the 29th Annual Congress of the European College of Neuropsychopharmacology.
    • 21 Oct 2014 Results of a post-hoc, pooled analysis of five 6-week, placebo-controlled, lurasidone trials were presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.
    • 09 Oct 2013 Efficacy and tolerability results from a pooled analysis presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top